We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+11.58%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$1.84B
AUM Growth
+$512M
Cap. Flow
+$511M
Cap. Flow %
27.7%
Top 10 Hldgs %
9.81%
Holding
1,111
New
387
Increased
195
Reduced
145
Closed
373

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$23.7M
2
DD icon
DuPont de Nemours
DD
+$15.1M
3
WYNN icon
Wynn Resorts
WYNN
+$12.7M
4
NVDA icon
NVIDIA
NVDA
+$9.64M
5
CI icon
Cigna
CI
+$9.64M

Sector Composition

Rank Sector Weight
1 Healthcare 21.83%
2 Consumer Discretionary 15.68%
3 Financials 12.95%
4 Industrials 12.38%
5 Technology 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WST icon
1001
West Pharmaceutical
WST
$23.7B
-11,641
Closed -$1.03M
X
1002
CALL
DELISTED
US Steel
X
-200,000
Closed -$107K
XLB icon
1003
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
-39,870
Closed -$1.14M
XLE icon
1004
State Street Energy Select Sector SPDR ETF
XLE
$39B
-30,822
Closed -$1.04M
XLF icon
1005
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
-7,532
Closed -$208K
XOM icon
1006
ExxonMobil
XOM
$650B
-16,875
Closed -$1.26M
XPO icon
1007
CALL
XPO
XPO
$23.4B
-433,709
Closed -$480K
YEXT icon
1008
Yext
YEXT
$573M
-10,017
Closed -$127K
ZION icon
1009
Zions Bancorporation
ZION
$10.1B
-7,858
Closed -$414K
AAMI
1010
Acadian Asset Management
AAMI
$2.88B
-20,369
Closed -$321K
PDCO
1011
DELISTED
Patterson Companies, Inc.
PDCO
-140,612
Closed -$3.13M
SUM
1012
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-12,039
Closed -$358K
RVNC
1013
DELISTED
Revance Therapeutics, Inc.
RVNC
-83,700
Closed -$2.58M
LUMO
1014
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-2,722
Closed -$177K
EGRX
1015
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-8,104
Closed -$427K
GTHX
1016
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-11,919
Closed -$442K
BIG
1017
DELISTED
Big Lots, Inc.
BIG
-37,474
Closed -$1.63M
DCPH
1018
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-30,146
Closed -$604K
NBSE
1019
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$0 ﹤0.01%
+32
New +$2.79K
PXD
1020
DELISTED
Pioneer Natural Resource Co.
PXD
-4,055
Closed -$696K
KAMN
1021
DELISTED
Kaman Corp
KAMN
-6,715
Closed -$418K
EXPR
1022
DELISTED
Express, Inc.
EXPR
-1,567
Closed -$224K
SRC
1023
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-4,140
Closed -$144K
GHL
1024
DELISTED
Greenhill & Co., Inc.
GHL
-34,291
Closed -$634K
INFI
1025
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-278,777
Closed -$585K

Similar funds

Schonfeld Strategic Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Schonfeld Strategic Advisors held 1,111 positions worth $1.84B, up 38% from $1.33B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Schonfeld Strategic Advisors deployed $511M of net new capital in Q2 2018, opening 387 new positions and adding to 195 existing holdings. Its largest new stake was Equitable Holdings: 1,082,300 shares worth $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Wynn Resorts, an estimated $12.7M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2018 buy was Equitable Holdings: 1,082,300 shares worth $22.3M.
  • Schonfeld Strategic Advisors added most to Sherwin-Williams in Q2 2018, an estimated $15.8M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2018 reduction was Wynn Resorts, cutting an estimated $12.7M.
  • Schonfeld Strategic Advisors fully exited Meta Platforms (Facebook) in Q2 2018, selling an estimated $23.7M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 9.8% of its $1.84B portfolio in Q2 2018.
  • Schonfeld Strategic Advisors opened 387 new positions and closed 373 in Q2 2018.
  • Schonfeld Strategic Advisors's portfolio value rose 38% quarter-over-quarter to $1.84B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.